К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

Liquid biopsy: testing tumor DNA in blood — when it helps and when it doesn't

A liquid biopsy looks for tumor DNA (ctDNA) in the blood. When it can replace a tissue biopsy, why a negative result doesn't rule out a mutation, and why it isn't screening.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026

In short

A liquid biopsy is a blood test that looks for fragments of tumor DNA (ctDNA, circulating tumor DNA). They can reveal mutations that have targeted drugs, without taking a piece of the tumor.

How it appears in your report

  • ‘ctDNA: EGFR exon 19 deletion, VAF 2.3%’ — a mutation was found, with its share of all DNA in the blood.
  • ‘EGFR T790M detected in plasma’ — a resistance mechanism to first-generation drugs.
  • ‘No tumor DNA detected’ — doesn't mean there is no mutation.

What it means

According to the US National Cancer Institute, a liquid biopsy makes it possible to look for mutations without an invasive procedure and to repeat the test during treatment. Today it is used mainly in advanced cancer — non-small cell lung, breast, prostate and colon cancer — to choose targeted therapy or understand why treatment has stopped working.

Limitations: with a small tumor burden there may be too little DNA in the blood, so a negative result needs checking on tissue. Sometimes the test picks up mutations that come not from the tumor but from age-related changes in blood cells (clonal hematopoiesis). For screening healthy people and for follow-up after treatment, the method is not yet routine standard.

Does it affect treatment

Yes, if a target is found — for example, EGFR or ALK: that is the basis for targeted therapy.

Questions to ask your doctor

  • Why a liquid biopsy rather than a tissue test (or the other way round)?
  • What happens if the result is negative?
  • Is the mutation found somatic, or could it be inherited?

Sources

  1. Liquid Biopsy: Using DNA in Blood to Detect, Track, and Treat Cancer — National Cancer Institute
  2. Targeted Drug Therapy for Non-small Cell Lung Cancer — American Cancer Society

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles